Skip to content
Screener

Amgen AMGN Total Revenue

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$22.97B+47.7%
Pfizer logo
PfizerPFE
$15.03B+2.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$4.29B+16.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$10.13M-9.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$58.82M+10.3%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.07B+19.1%

Segments

By product

See full
Repatha$3.02B
Other products$1.7B+23.0%
Prolia$759M-32.4%
EVENITY$714M+37.8%
ENBREL$580M-4.0%
TEPEZZA$576M+14.1%

By segment

See full
Reportable Segment$10.05B+9.5%

By geography

See full
ROW$8.38B

Other financials

Income statement

See full
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
Net income$2.4B+65.9%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation

See full
Market cap$238.06B+53.6%
Enterprise value$294.79B+39.9%
P/E27.2×+3.8×
P/S6.3×+1.8×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Amgen’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000318154-26-000126
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Revenues:
Product sales$9,537$8,771$17,755$16,644
Other revenues517408917684
Total revenues10,0549,17918,67217,328
Operating expenses:
Cost of sales2,8113,0115,5555,979
Research and development1,8681,7443,5873,230
Selling, general and administrative1,7451,6913,3473,378

Item 1. FINANCIAL STATEMENTS

FAQ

What is Amgen's total revenue?
Amgen (AMGN) reported total revenue of $10.05B in Q2 2026.
How has Amgen's total revenue changed year-over-year?
Amgen's total revenue increased by 9.5% year-over-year, from $9.18B to $10.05B.
What is the long-term trend for Amgen's total revenue?
Over 4 years (2021 to 2025), Amgen's total revenue has grown at a 9.1% compound annual growth rate (CAGR), from $25.98B to $36.75B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Amgen's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude